Potential new treatment for pancreatic cancertext editorEmerging Infectious Diseases
NMC-001 monoclonal antibody targets a specific pancreatic cancer marker and is able to selectively identify and diagnose pancreatic cancer in human. With a high affinity for its target, NMC-001 demonstrates potent anti-tumor efficiency in rodent models of pancreatic cancer. ...
Despite these improvements in treatment, pancreatic cancer is currently the fourth deadliest, and "it's climbing the ladder in terms of the number of people it kills," said Carl Schmidt, chief of the Surgical Oncology Division. "In my 10 years of being in practice, there's been more intere...
Embrace Self-Kindness During Cancer Treatment Going through cancer treatment can stir a wide range of emotions, often making it difficult to prioritize your own needs. Read More Understanding Your Risk Factors for Pancreatic Cancer It’s important to understand your personal risk factors so you can...
Drug Design, Development and Therapy Dovepress open access to scientific and medical research Open Access Full Text Article Review Pancreatic cancer: optimizing treatment options, new, and emerging targeted therapies This article was published in the following Dove Press journal: Drug Design, Development...
Pancreatic Cancer Prostate Cancer Stomach Cancer Other Cancers < > What Patients are saying about our Cancer Treatment Options Robin and Mark B. Nigel L. Wanda J. Kayla P. Manuela M. Stephanie D. Mark C. Jim C. Correna B. Behira and Mouhamad A. Michelle and Tyler H. Kim Cynth...
The direct-acting oral anticoagulant (DOAC) has become an alternative to low-molecular-weight heparin (LMWH) for treatment and prophylaxis of venous thromboembolism (VTE) in cancer patients. The clinicians are, however, faced with difficult decisions reg
New Hope's Unlimited alternative cancer treatment is a unique combination of traditional, alternative, and holistic cancer therapies. We believe in treating the body's immune system and that any treatment should be unique to a person. Call us at 888-272-
While many obstacles still exist, clearly we are making progress in deciphering the heterogeneity within pancreatic cancers. Integrating conventional and immunological targeting will be the key to effective treatment of this deadly disease. 展开 关键词: pancreatic cancer immunotherapies signaling pathway ...
Anaplastic lymphoma kinase (ALK) is a member of the insulin receptor protein-tyrosine kinase superfamily and was first discovered in anaplastic large-cell lymphoma (ALCL). ALK alterations, including fusions, over-expression and mutations, are highly associated with cancer initiation and progression. Thi...